NewslettersImmune Regulation News Review: Progress of the NLRP3 Inflammasome in Tumours and Perspectives for Cholangiocarcinoma By Emily Salmini - October 3, 2025 0 86 Researchers review the latest advancements in NLRP3 inflammasome research, including its regulatory mechanisms, role in promoting tumor development, and effects in anti-tumor immunotherapy. [Cell Communication and Signaling] Full Article